Poly Medicure Limited (POLYMED.BO)

INR 2628.7

(-3.48%)

EBITDA Summary of Poly Medicure Limited

Poly Medicure Limited's latest annual EBITDA in 2023 was 4.2 Billion INR , up 16.59% from previous year.
Poly Medicure Limited's latest quarterly EBITDA in 2024 Q1 was 1.03 Billion INR , up 8.32% from previous quarter.
Poly Medicure Limited reported an annual EBITDA of 3 Billion INR in 2022, up 26.21% from previous year.
Poly Medicure Limited reported an annual EBITDA of 2.52 Billion INR in 2021, up 4.95% from previous year.
Poly Medicure Limited reported a quarterly EBITDA of 1.42 Billion INR for 2024 Q2, up 17.66% from previous quarter.
Poly Medicure Limited reported a quarterly EBITDA of N/A for 2023 FY, up 16.59% from previous quarter.

Annual EBITDA Chart of Poly Medicure Limited (2023 - 2006)

Historical Annual EBITDA of Poly Medicure Limited (2023 - 2006)

Year	EBITDA	EBITDA Growth
2023	4.2 Billion INR	16.59%
2022	3 Billion INR	26.21%
2021	2.52 Billion INR	4.95%
2020	2.33 Billion INR	26.22%
2019	1.76 Billion INR	23.54%
2018	1.5 Billion INR	9.93%
2017	1.36 Billion INR	29.34%
2016	1.07 Billion INR	10.95%
2015	857.76 Million INR	4.72%
2014	1.11 Billion INR	19.69%
2013	752.37 Million INR	44.77%
2012	518.42 Million INR	9.11%
2011	454.61 Million INR	29.52%
2010	367.77 Million INR	27.47%
2009	287.95 Million INR	61.94%
2008	177.59 Million INR	1.01%
2007	175.81 Million INR	6.48%
2006	165.64 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	1.03 Billion INR	8.32%
2024 Q2	1.42 Billion INR	17.66%
2023 FY	- INR	16.59%
2023 Q3	1.07 Billion INR	8.42%
2023 Q4	965.79 Million INR	-10.16%
2023 Q1	1.01 Billion INR	9.85%
2023 Q2	991.56 Million INR	-1.88%
2022 Q2	739.55 Million INR	43.78%
2022 Q1	514.37 Million INR	-19.25%
2022 FY	- INR	26.21%
2022 Q4	919.96 Million INR	7.21%
2022 Q3	858.11 Million INR	16.03%
2021 FY	- INR	4.95%
2021 Q2	641.12 Million INR	-3.24%
2021 Q3	511.52 Million INR	-20.21%
2021 Q4	636.97 Million INR	24.52%
2021 Q1	662.58 Million INR	7.29%
2020 FY	- INR	26.22%
2020 Q4	617.58 Million INR	-2.53%
2020 Q1	500.14 Million INR	8.38%
2020 Q2	601.81 Million INR	20.33%
2020 Q3	633.6 Million INR	5.28%
2019 Q1	409.6 Million INR	0.89%
2019 FY	- INR	23.54%
2019 Q3	498.41 Million INR	5.36%
2019 Q2	473.04 Million INR	15.49%
2019 Q4	461.47 Million INR	-7.41%
2018 Q4	405.99 Million INR	34.06%
2018 FY	- INR	9.93%
2018 Q3	302.84 Million INR	-22.26%
2018 Q2	389.54 Million INR	12.61%
2018 Q1	345.91 Million INR	-10.6%
2017 Q3	331.23 Million INR	0.0%
2017 Q4	386.91 Million INR	16.81%
2017 FY	- INR	29.34%
2016 FY	- INR	10.95%
2015 FY	- INR	4.72%
2014 FY	- INR	19.69%
2013 FY	- INR	44.77%
2012 Q1	90.15 Million INR	0.0%
2012 Q3	165.71 Million INR	85.31%
2012 Q4	170.28 Million INR	2.76%
2012 FY	- INR	9.11%
2012 Q2	89.42 Million INR	-0.8%
2011 FY	- INR	29.52%
2010 FY	- INR	27.47%
2009 FY	- INR	61.94%
2008 FY	- INR	1.01%
2007 FY	- INR	6.48%
2006 FY	- INR	0.0%

Peer EBITDA Comparison of Poly Medicure Limited

Name	EBITDA	EBITDA Difference
Tarsons Products Limited	1.11 Billion INR	-277.335%